1 The primary outcome
was the proportion of children developing histologically prov
2 The primary outcome
was the proportion of clinical failures (development of sever
3 nce and lower leg longitudinal growth were also similar, as
was the proportion of cumulative total enteral feeding volume
4 The primary outcome
was the proportion of duodenoscopes with an elevator mechanis
5 The primary outcome
was the proportion of households in which at least one child
6 The primary outcome
was the proportion of individuals testing with a partner.
7 The primary outcome
was the proportion of individuals who had one or more osteopo
8 The primary endpoint
was the proportion of participants achieving sustained virolo
9 The primary endpoint
was the proportion of participants achieving sustained virolo
10 The primary outcome
was the proportion of participants in whom a diagnosis of cur
11 The primary outcome
was the proportion of participants with culture-positive pulm
12 The primary endpoint
was the proportion of participants with HIV-1 RNA less than 4
13 The primary endpoint
was the proportion of participants with less than 50 copies p
14 The primary outcome
was the proportion of participants with plasma HIV-1 RNA conc
15 The primary endpoint
was the proportion of participants with plasma HIV-1 RNA of l
16 The primary endpoint
was the proportion of participants with plasma HIV-1 RNA of l
17 The non-inferiority primary effectiveness outcome
was the proportion of participants with three or fewer bliste
18 The primary endpoint
was the proportion of participants with undetectable HIV-RNA
19 The primary outcome
was the proportion of participants with virological rebound (
20 The primary efficacy measure
was the proportion of patients achieving a >/=50% reduction i
21 The primary endpoint
was the proportion of patients achieving an objective (comple
22 The primary efficacy end point
was the proportion of patients achieving greater than 30% red
23 The primary endpoint
was the proportion of patients achieving haematocrit control
24 A secondary efficacy end point
was the proportion of patients achieving mean PTH of 300 pg/m
25 The primary endpoint
was the proportion of patients considered responders at 24 h.
26 The primary end point
was the proportion of patients having at least 1 skeletal-rel
27 The primary endpoint
was the proportion of patients in each group with an mUFC con
28 The primary endpoint
was the proportion of patients in the intention-to-treat popu
29 The primary outcome
was the proportion of patients receiving the preferred beta-l
30 The primary efficacy outcome
was the proportion of patients remaining free from seizures f
31 Primary outcome
was the proportion of patients returning to preoperative func
32 The primary end point
was the proportion of patients who achieved a >/=1.0 g/dl inc
33 The primary endpoint for this study
was the proportion of patients who achieved an overall respon
34 The primary endpoint
was the proportion of patients who attained an American Colle
35 The primary efficacy end point
was the proportion of patients who developed AKI according to
36 The primary outcome
was the proportion of patients who received antibiotics while
37 The primary end point
was the proportion of patients with 1 or more SRE on study (S
38 The primary outcome
was the proportion of patients with a CIDP relapse or who wer
39 The primary endpoint of the initial study
was the proportion of patients with a haematological response
40 Primary outcome measure
was the proportion of patients with a stable retinal reattach
41 The primary outcome
was the proportion of patients with an adequate clinical and
42 The primary end point
was the proportion of patients with complete clinical respons
43 The primary outcome
was the proportion of patients with microbiologically documen
44 The primary outcome
was the proportion of patients with successful first-pass int
45 The primary outcome
was the proportion of patients with successful revascularizat
46 The primary efficacy endpoint
was the proportion of patients with SVR at 12 weeks after tre
47 Exposure
was the proportion of pregnancy protected by IRS.
48 The primary end point
was the proportion of subjects developing at least 1 small-bo
49 The primary outcome
was the proportion of success at 12 months, defined as improv
50 The primary outcome
was the proportion of time when sensor glucose concentration